From Marketwatch:
A great thing about living in New York City as an investor is that, sooner or later, almost everyone who is anyone in the financial markets passes through, and often I get to meet to talk over ideas.
The annual Jefferies Global Healthcare Conference every June is an example. This year it featured about 400 biotechnology companies. There was also a “view from the buy side” panel featuring three money managers with good records and a collective 60 years of experience.
Here’s their take on why this is a great time to invest in biotech, how to maneuver and what to avoid.